IN THIS ISSUE

Legislation & Regulation
John Carroll
The new system is supposed to have transparent pricing, but some say it is susceptible to manipulation, which was AWP’s downfall
Medication Management
Thomas Reinke
Developers make progress with genetic markers aimed at improving drug response
Tomorrow's Medicine
Thomas Morrow, MD
The FDA will make a final determination on regulations intended to permit the sale of ‘follow-on’ biologics
News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report